Expanding the scope of site-specific recombinases for genetic and metabolic engineering

Biotechnology and Bioengineering

Volumn 111, Issue 1, 2014, Pages 1-15

  Gaj, Thomas ^a   Sirk, Shannon J ^a   Barbas, Carlos F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Genome engineering; Protein engineering; Recombinase

Indexed keywords

BIOLOGICAL FUNCTIONS; CELLULAR STRUCTURE; GENOME ENGINEERING; MOLECULAR EVOLUTION; PROTEIN ENGINEERING; RECOGNITION ABILITIES; RECOMBINASE; SITE-SPECIFIC RECOMBINATION;

BIOCHEMICAL ENGINEERING;

GENETIC ENGINEERING;

DNA; INTEGRASE; RECOMBINASE; SITE SPECIFIC RECOMBINASE; UNCLASSIFIED DRUG;

DIRECTED MOLECULAR EVOLUTION; DNA RECOMBINATION; GENETIC ENGINEERING; METABOLIC ENGINEERING; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN ENGINEERING; REVIEW; SACCHAROMYCES CEREVISIAE; STREPTOMYCES; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; HUMAN; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; GENETIC ENGINEERING; HUMANS; METABOLIC ENGINEERING; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECOMBINASES;

EID: 84888059635     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25096     Document Type: Review

References (153)

1. Abdel-Meguid SS, Grindley ND, Templeton NS, Steitz TA. 1984. Cleavage of the site-specific recombination protein gamma delta resolvase: The smaller of two fragments binds DNA specifically. Proc Natl Acad Sci USA 81(7):2001-2005.
2. Abi-Ghanem J, Chusainow J, Karimova M, Spiegel C, Hofmann-Sieber H, Hauber J, Buchholz F, Pisabarro MT. 2013. Engineering of a target site-specific recombinase by a combined evolution- and structure-guided approach. Nucl Acids Res 41(4):2394-2403.
3. Akopian A, He J, Boocock MR, Stark WM. 2003. Chimeric recombinases with designed DNA sequence recognition. Proc Natl Acad Sci USA 100(15):8688-8691.
4. Andrews BJ, Proteau GA, Beatty LG, Sadowski PD. 1985. The FLP recombinase of the 2 micron circle DNA of yeast: Interaction with its target sequences. Cell 40(4):795-803.
5. Arnold PH, Blake DG, Grindley ND, Boocock MR, Stark WM. 1999. Mutants of Tn3 resolvase which do not require accessory binding sites for recombination activity. EMBO J 18(5):1407-1414.
6. Baldwin EP, Martin SS, Abel J, Gelato KA, Kim H, Schultz PG, Santoro SW. 2003. A specificity switch in selected cre recombinase variants is mediated by macromolecular plasticity and water. Chem Biol 10(11):1085-1094.
7. Beerli RR, Barbas CF, III. 2002. Engineering polydactyl zinc-finger transcription factors. Nat Biotech 20(2):135-141.
8. Beerli RR, Segal DJ, Dreier B, Barbas CF, III. 1998. Toward controlling gene expression at will: Specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci USA 95(25):14628-14633.
9. Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA. 2006. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proc Natl Acad Sci USA 103(2):419-424.
10. Biswas T, Aihara H, Radman-Livaja M, Filman D, Landy A, Ellenberger T. 2005. A structural basis for allosteric control of DNA recombination by lambda integrase. Nature 435(7045):1059-1066.
11. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U. 2009. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326(5959):1509-1512.
12. Bolusani S, Ma CH, Paek A, Konieczka JH, Jayaram M, Voziyanov Y. 2006. Evolution of variants of yeast site-specific recombinase Flp that utilize native genomic sequences as recombination target sites. Nucl Acids Res 34(18):5259-5269.
13. Bonnet J, Subsoontorn P, Endy D. 2012. Rewritable digital data storage in live cells via engineered control of recombination directionality. Proc Natl Acad Sci USA 109(23):8884-8889.
14. Bonnet J, Yin P, Ortiz ME, Subsoontorn P, Endy D. 2013. Amplifying genetic logic gates. Science 340(6132):599-603.
15. Branda CS, Dymecki SM. 2004. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6(1):7-28.
16. Broach JR, Hicks JB. 1980. Replication and recombination functions associated with the yeast plasmid, 2mu circle. Cell 21(2):501-508.
17. Broach JR, Guarascio VR, Jayaram M. 1982. Recombination within the yeast plasmid 2mu circle is site-specific. Cell 29(1):227-234.
18. Bruckner RC, Cox MM. 1986. Specific contacts between the FLP protein of the yeast 2-micron plasmid and its recombination site. J Biol Chem 261(25):11798-11807.
19. Buchholz F, Stewart AF. 2001. Alteration of Cre recombinase site specificity by substrate-linked protein evolution. Nat Biotechnol 19(11):1047-1052.
20. Buchholz F, Ringrose L, Angrand PO, Rossi F, Stewart AF. 1996. Different thermostabilities of FLP and Cre recombinases: Implications for applied site-specific recombination. Nucl Acids Res 24(21):4256-4262.
21. Buchholz F, Angrand PO, Stewart AF. 1998. Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat Biotechnol 16(7):657-662.
22. Cadwell RC, Joyce GF. 1992. Randomization of genes by PCR mutagenesis. PCR Methods Appl 2(1):28-33.
23. Carroll D. 2011. Genome engineering with zinc-finger nucleases. Genetics 188(4):773-782.
24. Cedrone F, Menez A, Quemeneur E. 2000. Tailoring new enzyme functions by rational redesign. Curr Opin Struct Biol 10(4):405-410.
25. Chalberg TW, Portlock JL, Olivares EC, Thyagarajan B, Kirby PJ, Hillman RT, Hoelters J, Calos MP. 2006. Integration specificity of phage phiC31 integrase in the human genome. J Mol Biol 357(1):28-48.
26. Chen Y, Rice PA. 2003. New insight into site-specific recombination from Flp recombinase-DNA structures. Annu Rev Biophys Biomol Struct 32:135-159.
27. Chen Y, Narendra U, Iype LE, Cox MM, Rice PA. 2000. Crystal structure of a Flp recombinase-Holliday junction complex: Assembly of an active oligomer by helix swapping. Mol Cell 6(4):885-897.
28. Chen XL, Reindle A, Johnson ES. 2005. Misregulation of 2 microm circle copy number in a SUMO pathway mutant. Mol Cell Biol 25(10):4311-4320.
29. Cheng AA, Lu TK. 2012. Synthetic biology: An emerging engineering discipline. Annu Rev Biomed Eng 14:155-178.
30. Christ N, Corona T, Droge P. 2002. Site-specific recombination in eukaryotic cells mediated by mutant lambda integrases: Implications for synaptic complex formation and the reactivity of episomal DNA segments. J Mol Biol 319(2):305-314.
31. Cohen HM, Tawfik DS, Griffiths AD. 2004. Altering the sequence specificity of HaeIII methyltransferase by directed evolution using in vitro compartmentalization. Protein Eng Des Sel 17(1):3-11.
32. Conway AB, Chen Y, Rice PA. 2003. Structural plasticity of the Flp-Holliday junction complex. J Mol Biol 326(2):425-434.
33. Dale EC, Ow DW. 1991. Gene transfer with subsequent removal of the selection gene from the host genome. Proc Natl Acad Sci USA 88(23):10558-10562.
34. Deng D, Yan C, Pan X, Mahfouz M, Wang J, Zhu JK, Shi Y, Yan N. 2012. Structural basis for sequence-specific recognition of DNA by TAL effectors. Science 335(6069):720-723.
35. Doi N, Kumadaki S, Oishi Y, Matsumura N, Yanagawa H. 2004. In vitro selection of restriction endonucleases by in vitro compartmentalization. Nucl Acids Res 32(12):e95.
36. Dorgai L, Yagil E, Weisberg RA. 1995. Identifying determinants of recombination specificity: Construction and characterization of mutant bacteriophage integrases. J Mol Biol 252(2):178-188.
37. Doyon Y, McCammon JM, Miller JC, Faraji F, Ngo C, Katibah GE, Amora R, Hocking TD, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Amacher SL. 2008. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol 26(6):702-708.
38. Dreier B, Beerli RR, Segal DJ, Flippin JD, Barbas CF, III. 2001. Development of zinc finger domains for recognition of the 5′-ANN-3′ family of DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 276(31):29466-29478.
39. Dreier B, Fuller RP, Segal DJ, Lund CV, Blancafort P, Huber A, Koksch B, Barbas CF, III. 2005. Development of zinc finger domains for recognition of the 5′-CNN-3′ family DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 280(42):35588-35597.
40. Ehrhardt A, Engler JA, Xu H, Cherry AM, Kay MA. 2006. Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration. Hum Gene Ther 17(11):1077-1094.
41. Esvelt KM, Carlson JC, Liu DR. 2011. A system for the continuous directed evolution of biomolecules. Nature 472(7344):499-503.
42. Eustaquio AS, Gust B, Galm U, Li SM, Chater KF, Heide L. 2005. Heterologous expression of novobiocin and clorobiocin biosynthetic gene clusters. Appl Environ Microbiol 71(5):2452-2459.
43. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. 1996. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 93(20):10887-10890.
44. Fen CX, Coomber DW, Lane DP, Ghadessy FJ. 2007. Directed evolution of p53 variants with altered DNA-binding specificities by in vitro compartmentalization. J Mol Biol 371(5):1238-1248.
45. Fukushige S, Sauer B. 1992. Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci USA 89(17):7905-7909.
46. Gabriel R, Lombardo A, Arens A, Miller JC, Genovese P, Kaeppel C, Nowrouzi A, Bartholomae CC, Wang J, Friedman G, et al. 2011. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 29(9):816-823.
47. Gaj T, Mercer AC, Gersbach CA, Gordley RM, Barbas CF, III. 2011. Structure-guided reprogramming of serine recombinase DNA sequence specificity. Proc Natl Acad Sci USA 108(2):498-503.
48. Gaj T, Guo J, Kato Y, Sirk SJ, Barbas CF, III. 2012. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods 9(8):805-807.
49. Gaj T, Gersbach CA, Barbas CF, III. 2013a. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31(7):397-405.
50. Gaj T, Mercer AC, Sirk SJ, Smith HL, Barbas CF, III. 2013b. A comprehensive approach to zinc-finger recombinase customization enables genomic targeting in human cells. Nucl Acids Res 41(6):3937-3946.
51. Gersbach CA, Gaj T, Gordley RM, Barbas CF, III. 2010. Directed evolution of recombinase specificity by split gene reassembly. Nucl Acids Res 38(12):4198-4206.
52. Gersbach CA, Gaj T, Gordley RM, Mercer AC, Barbas CF, III. 2011. Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase. Nucl Acids Res 39(17):7868-7878.
53. Ghadessy FJ, Ong JL, Holliger P. 2001. Directed evolution of polymerase function by compartmentalized self-replication. Proc Natl Acad Sci USA 98(8):4552-4557.
54. Ghosh P, Kim AI, Hatfull GF. 2003. The orientation of mycobacteriophage Bxb1 integration is solely dependent on the central dinucleotide of attP and attB. Mol Cell 12(5):1101-1111.
55. Gordley RM, Smith JD, Graslund T, Barbas CF, III. 2007. Evolution of programmable zinc finger-recombinases with activity in human cells. J Mol Biol 367(3):802-813.
56. Gordley RM, Gersbach CA, Barbas CF, III. 2009. Synthesis of programmable integrases. Proc Natl Acad Sci USA 106(13):5053-5058.
57. Grainge I, Jayaram M. 1999. The integrase family of recombinase: Organization and function of the active site. Mol Microbiol 33(3):449-456.
58. Grindley ND, Whiteson KL, Rice PA. 2006. Mechanisms of site-specific recombination. Annu Rev Biochem 75:567-605.
59. Groth AC, Calos MP. 2004. Phage integrases: Biology and applications. J Mol Biol 335(3):667-678.
60. Groth AC, Olivares EC, Thyagarajan B, Calos MP. 2000. A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci USA 97(11):5995-6000.
61. Guo F, Gopaul DN, van Duyne GD. 1997. Structure of Cre recombinase complexed with DNA in a site-specific recombination synapse. Nature 389(6646):40-46.
62. Guo J, Gaj T, Barbas CF, III. 2010. Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases. J Mol Biol 400(1):96-107.
63. Hartley JL, Donelson JE. 1980. Nucleotide sequence of the yeast plasmid. Nature 286(5776):860-865.
64. Hartung M, Kisters-Woike B. 1998. Cre mutants with altered DNA binding properties. J Biol Chem 273(36):22884-22891.
65. Hoess RH, Abremski K. 1985. Mechanism of strand cleavage and exchange in the Cre-lox site-specific recombination system. J Mol Biol 181(3):351-362.
66. Hoess RH, Ziese M, Sternberg N. 1982. P1 site-specific recombination: Nucleotide sequence of the recombining sites. Proc Natl Acad Sci USA 79(11):3398-3402.
67. Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC, et al., 2010. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 28(8):839-847.
68. Isalan M, Klug A, Choo Y. 2001. A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol 19(7):656-660.
69. Jackel C, Kast P, Hilvert D. 2008. Protein design by directed evolution. Annu Rev Biophys 37:153-173.
70. Jantama K, Haupt MJ, Svoronos SA, Zhang X, Moore JC, Shanmugam KT, Ingram LO. 2008. Combining metabolic engineering and metabolic evolution to develop nonrecombinant strains of Escherichia coli C that produce succinate and malate. Biotechnol Bioeng 99(5):1140-1153.
71. Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, Ruley HE. 2001. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol 19(10):929-933.
72. Karimova M, Abi-Ghanem J, Berger N, Surendranath V, Pisabarro MT, Buchholz F. 2013. Vika/vox, a novel efficient and specific Cre/loxP-like site-specific recombination system. Nucl Acids Res 41(2):e37.
73. Kay MA, He CY, Chen ZY. 2010. A robust system for production of minicircle DNA vectors. Nat Biotechnol 28(12):1287-1289.
74. Keravala A, Portlock JL, Nash JA, Vitrant DG, Robbins PD, Calos MP. 2006. PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints. J Gene Med 8(8):1008-1017.
75. Keravala A, Lee S, Thyagarajan B, Olivares EC, Gabrovsky VE, Woodard LE, Calos MP. 2009. Mutational derivatives of PhiC31 integrase with increased efficiency and specificity. Mol Ther 17(1):112-120.
76. Kim AI, Ghosh P, Aaron MA, Bibb LA, Jain S, Hatfull GF. 2003. Mycobacteriophage Bxb1 integrates into the Mycobacterium smegmatis groEL1 gene. Mol Microbiol 50(2):463-473.
77. Klippel A, Cloppenborg K, Kahmann R. 1988. Isolation and characterization of unusual gin mutants. EMBO J 7(12):3983-3989.
78. Kolot M, Meroz A, Yagil E. 2003. Site-specific recombination in human cells catalyzed by the wild-type integrase protein of coliphage HK022. Biotechnol Bioeng 84(1):56-60.
79. Kuhn R, Schwenk F, Aguet M, Rajewsky K. 1995. Inducible gene targeting in mice. Science 269(5229):1427-1429.
80. Leconte AM, Dickinson BC, Yang DD, Chen IA, Allen B, Liu DR. 2013. A population-based experimental model for protein evolution: Effects of mutation rate and selection stringency on evolutionary outcomes. Biochemistry 52(8):1490-1499.
81. Liesner R, Zhang W, Noske N, Ehrhardt A. 2010. Critical amino acid residues within the phiC31 integrase DNA-binding domain affect recombination activities in mammalian cells. Hum Gene Ther 21(9):1104-1118.
82. Liu P, Jenkins NA, Copeland NG. 2003. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res 13(3):476-484.
83. Liu J, Jeppesen I, Nielsen K, Jensen TG. 2006. Phi c31 integrase induces chromosomal aberrations in primary human fibroblasts. Gene Ther 13(15):1188-1190.
84. Logie C, Stewart AF. 1995. Ligand-regulated site-specific recombination. Proc Natl Acad Sci USA 92(13):5940-5944.
85. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R, Berns A, Jonkers J. 2001. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98(16):9209-9214.
86. Lorbach E, Christ N, Schwikardi M, Droge P. 2000. Site-specific recombination in human cells catalyzed by phage lambda integrase mutants. J Mol Biol 296(5):1175-1181.
87. Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M, Jiang T, Foley JE, Winfrey RJ, Townsend JA, et al. 2008. Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell 31(2):294-301.
88. Mak AN, Bradley P, Cernadas RA, Bogdanove AJ, Stoddard BL. 2012. The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 335(6069):716-719.
89. Malla S, Dafhnis-Calas F, Brookfield JF, Smith MC, Brown WR. 2005. Rearranging the centromere of the human Y chromosome with phiC31 integrase. Nucl Acids Res 33(19):6101-6113.
90. Mercer AC, Gaj T, Fuller RP, Barbas CF, III. 2012. Chimeric TALE recombinases with programmable DNA sequence specificity. Nucl Acids Res 40(21):11163-11172.
91. Miller HI, Mozola MA, Friedman DI. 1980. int-h: An int mutation of phage lambda that enhances site-specific recombination. Cell 20(3):721-729.
92. Moscou MJ, Bogdanove AJ. 2009. A simple cipher governs DNA recognition by TAL effectors. Science 326(5959):1501.
93. Nagy A. 2000. Cre recombinase: The universal reagent for genome tailoring. Genesis 26(2):99-109.
94. Nern A, Pfeiffer BD, Svoboda K, Rubin GM. 2011. Multiple new site-specific recombinases for use in manipulating animal genomes. Proc Natl Acad Sci USA 108(34):14198-14203.
95. Nkrumah LJ, Muhle RA, Moura PA, Ghosh P, Hatfull GF, Jacobs WR, Jr., Fidock DA. 2006. Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase. Nat Methods 3(8):615-621.
96. Nomura W, Masuda A, Ohba K, Urabe A, Ito N, Ryo A, Yamamoto N, Tamamura H. 2012. Effects of DNA binding of the zinc finger and linkers for domain fusion on the catalytic activity of sequence-specific chimeric recombinases determined by a facile fluorescent system. Biochemistry 51(7):1510-1517.
97. O'Gorman S, Fox DT, Wahl GM. 1991. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251(4999):1351-1355.
98. Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP. 2002. Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol 20(11):1124-1128.
99. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Fang M, Calos MP, Khavari PA. 2002. Stable nonviral genetic correction of inherited human skin disease. Nat Med 8(10):1166-1170.
100. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Calos MP, Khavari PA. 2003. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum Gene Ther 14(9):923-928.
101. Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F. 2002. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: A tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci USA 99(7):4489-4494.
102. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O, Wang N, Lee G, Bartsevich VV, Lee YL, et al. 2008. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26(7):808-816.
103. Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM. 2001. Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting in vivo. Proc Natl Acad Sci USA 98(20):11450-11455.
104. Portlock JL, Keravala A, Bertoni C, Lee S, Rando TA, Calos MP. 2006. Long-term increase in mVEGF164 in mouse hindlimb muscle mediated by phage phiC31 integrase after nonviral DNA delivery. Hum Gene Ther 17(8):871-876.
105. Prorocic MM, Wenlong D, Olorunniji FJ, Akopian A, Schloetel JG, Hannigan A, McPherson AL, Stark WM. 2011. Zinc-finger recombinase activities in vitro. Nucl Acids Res 39(21):9316-9328.
106. Proudfoot C, McPherson AL, Kolb AF, Stark WM. 2011. Zinc finger recombinases with adaptable DNA sequence specificity. PLoS ONE 6(4):e19537.
107. Ramirez-Solis R, Liu P, Bradley A. 1995. Chromosome engineering in mice. Nature 378(6558):720-724.
108. Rodriguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R, Stewart AF, Dymecki SM. 2000. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet 25(2):139-140.
109. Rutherford K, Yuan P, Perry K, Sharp R, Van Duyne GD. 2013. Attachment site recognition and regulation of directionality by the serine integrases. Nucl Acids Res. Advance online publication. doi:10.1093/nar/gkt580
110. Rutkai E, Dorgai L, Sirot R, Yagil E, Weisberg RA. 2003. Analysis of insertion into secondary attachment sites by phage lambda and by int mutants with altered recombination specificity. J Mol Biol 329(5):983-996.
111. Sander JD, Dahlborg EJ, Goodwin MJ, Cade L, Zhang F, Cifuentes D, Curtin SJ, Blackburn JS, Thibodeau-Beganny S, Qi Y, et al. 2011. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nat Methods 8(1):67-69.
112. Sanderson MR, Freemont PS, Rice PA, Goldman A, Hatfull GF, Grindley ND, Steitz TA. 1990. The crystal structure of the catalytic domain of the site-specific recombination enzyme gamma delta resolvase at 2.7 A resolution. Cell 63(6):1323-1329.
113. Santoro SW, Schultz PG. 2002. Directed evolution of the site specificity of Cre recombinase. Proc Natl Acad Sci USA 99(7):4185-4190.
114. Sarkar I, Hauber I, Hauber J, Buchholz F. 2007. HIV-1 proviral DNA excision using an evolved recombinase. Science 316(5833):1912-1915.
115. Sauer B, Henderson N. 1990. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol 2(5):441-449.
116. Sauer B, McDermott J. 2004. DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages. Nucl Acids Res 32(20):6086-6095.
117. Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR. 2000. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97(25):13702-13707.
118. Sclimenti CR, Thyagarajan B, Calos MP. 2001. Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucl Acids Res 29(24):5044-5051.
119. Segal DJ, Dreier B, Beerli RR, Barbas CF, III. 1999. Toward controlling gene expression at will: Selection and design of zinc finger domains recognizing each of the 5′-GNN-3′ DNA target sequences. Proc Natl Acad Sci USA 96(6):2758-2763.
120. Shendure J, Lieberman Aiden E. 2012. The expanding scope of DNA sequencing. Nat Biotechnol 30(11):1084-1094.
121. Shultz JL, Voziyanova E, Konieczka JH, Voziyanov Y. 2011. A genome-wide analysis of FRT-like sequences in the human genome. PLoS ONE 6(3):e18077.
122. Siuti P, Yazbek J, Lu TK. 2013. Synthetic circuits integrating logic and memory in living cells. Nat Biotechnol 31(5):448-452.
123. Smith MC, Thorpe HM. 2002. Diversity in the serine recombinases. Mol Microbiol 44(2):299-307.
124. Smith AJ, De Sousa MA, Kwabi-Addo B, Heppell-Parton A, Impey H, Rabbitts P. 1995. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nat Genet 9(4):376-385.
125. Stemmer WP. 1994a. DNA shuffling by random fragmentation and reassembly: In vitro recombination for molecular evolution. Proc Natl Acad Sci USA 91(22):10747-10751.
126. Stemmer WP. 1994b. Rapid evolution of a protein in vitro by DNA shuffling. Nature 370(6488):389-391.
127. Surendranath V, Chusainow J, Hauber J, Buchholz F, Habermann BH. 2010. SeLOX-A locus of recombination site search tool for the detection and directed evolution of site-specific recombination systems. Nucl Acids Res 38(Web Server issue):W293-W298.
128. Suzuki E, Nakayama M. 2011. VCre/VloxP and SCre/SloxP: New site-specific recombination systems for genome engineering. Nucl Acids Res 39(8):e49.
129. Tawfik DS, Griffiths AD. 1998. Man-made cell-like compartments for molecular evolution. Nat Biotechnol 16(7):652-656.
130. Tay Y, Ho C, Droge P, Ghadessy FJ. 2010. Selection of bacteriophage lambda integrases with altered recombination specificity by in vitro compartmentalization. Nucl Acids Res 38(4):e25.
131. Thorpe HM, Smith MC. 1998. In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci USA 95(10):5505-5510.
132. Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP. 2000. Mammalian genomes contain active recombinase recognition sites. Gene 244(1-2):47-54.
133. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP. 2001. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 21(12):3926-3934.
134. Thyagarajan B, Liu Y, Shin S, Lakshmipathy U, Scheyhing K, Xue H, Ellerstrom C, Strehl R, Hyllner J, Rao MS, et al. 2008. Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells 26(1):119-126.
135. Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, Mayford M, Kandel ER, Tonegawa S. 1996. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87(7):1317-1326.
136. Umana P, Gerdes CA, Stone D, Davis JR, Ward D, Castro MG, Lowenstein PR. 2001. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nat Biotechnol 19(6):582-585.
137. Van Duyne GD. 2001. A structural view of Cre-loxP site-specific recombination. Annu Rev Biophys Biomol Struct 30:87-104.
138. Voziyanov Y, Stewart AF, Jayaram M. 2002. A dual reporter screening system identifies the amino acid at position 82 in Flp site-specific recombinase as a determinant for target specificity. Nucl Acids Res 30(7):1656-1663.
139. Voziyanov Y, Konieczka JH, Stewart AF, Jayaram M. 2003. Stepwise manipulation of DNA specificity in Flp recombinase: Progressively adapting Flp to individual and combinatorial mutations in its target site. J Mol Biol 326(1):65-76.
140. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L. 1997. Cre-mediated gene deletion in the mammary gland. Nucl Acids Res 25(21):4323-4330.
141. Wang Y, Krushel LA, Edelman GM. 1996. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene. Proc Natl Acad Sci USA 93(9):3932-3936.
142. Whiteson KL, Rice PA. 2008. Binding and catalytic contributions to site recognition by flp recombinase. J Biol Chem 283(17):11414-11423.
143. Wu Z, Gumport RI, Gardner JF. 1997. Genetic analysis of second-site revertants of bacteriophage lambda integrase mutants. J Bacteriol 179(12):4030-4038.
144. Wyman C, Kanaar R. 2006. DNA double-strand break repair: All's well that ends well. Annu Rev Genet 40:363-383.
145. Xiong L, Chen XL, Silver HR, Ahmed NT, Johnson ES. 2009. Deficient SUMO attachment to Flp recombinase leads to homologous recombination-dependent hyperamplification of the yeast 2 microm circle plasmid. Mol Biol Cell 20(4):1241-1251.
146. Yagil E, Dolev S, Oberto J, Kislev N, Ramaiah N, Weisberg RA. 1989. Determinants of site-specific recombination in the lambdoid coliphage HK022. An evolutionary change in specificity. J Mol Biol 207(4):695-717.
147. Yagil E, Dorgai L, Weisberg RA. 1995. Identifying determinants of recombination specificity: Construction and characterization of chimeric bacteriophage integrases. J Mol Biol 252(2):163-177.
148. Yang W, Steitz TA. 1995. Crystal structure of the site-specific recombinase gamma delta resolvase complexed with a 34bp cleavage site. Cell 82(2):193-207.
149. Ye L, Chang JC, Lin C, Qi Z, Yu J, Kan YW. 2010. Generation of induced pluripotent stem cells using site-specific integration with phage integrase. Proc Natl Acad Sci USA 107(45):19467-19472.
150. Yuan L, Kurek I, English J, Keenan R. 2005. Laboratory-directed protein evolution. Microbiol Mol Biol Rev 69(3):373-392.
151. Yuan LZ, Rouviere PE, Larossa RA, Suh W. 2006. Chromosomal promoter replacement of the isoprenoid pathway for enhancing carotenoid production in E. coli. Metab Eng 8(1):79-90.
152. Yuan J, Wang J, Crain K, Fearns C, Kim KA, Hua KL, Gregory PD, Holmes MC, Torbett BE. 2012. Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment. Mol Ther 20(4):849-859.
153. Yuen CM, Liu DR. 2007. Dissecting protein structure and function using directed evolution. Nat Methods 4(12):995-997.